Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 8,402

Document Document Title
WO/2014/094462A1
The present invention provides a biological preparation method of (S)-3-methylamino-1-(2-thienyl)-1-propyl alcohol, wherein 3-methylamino-1-(2-thienyl)-1-acetone is used as a substrate; under a condition that a biocatalyst ketoreductase,...  
WO/2014/086702A3
The present invention relates to a biocatalytic process for preparing furandimethanols from hydroxymethylfurfurals, catalysed by suitable alcohol dehydrogenase enzymes, and to the use of the dimethanols thus prepared for preparation of o...  
WO/2014/080666A1
A diterpene compound represented by formula (VII) is a novel diterpene compound having an excellent skin-whitening effect. The present invention provides: a skin-whitening agent comprising a novel diterpene compound; and a method for pro...  
WO/2014/056006A1
The invention relates to enzymes for transforming ergopeptines, in particular by means of hydrolytic cleavage. Said enzymes are α/ β hydrolases which are hydrolytically cleaved in the cyclol ring of the ergopeptines for the transformat...  
WO/2014/056007A3
The invention relates to an enzyme preparation for transforming ergopeptines, containing at least one α/ß hydrolase which is hydrolytically cleaved in the cyclol ring of the ergopeptines and at least one amidase transforming the degrad...  
WO/2014/056007A2
The invention relates to an enzyme preparation for transforming ergopeptines, containing at least one α/ß hydrolase which is hydrolytically cleaved in the cyclol ring of the ergopeptines and at least one amidase transforming the degrad...  
WO/2014/036395A1
The invention provides a series of bioactive small molecules that target expanded r(CGG) repeats, termed r(CGG)exp, that causes Fragile X-associated Tremor Ataxia Syndrome (FXTAS). The compound was identified by using information on the ...  
WO/2014/030106A3
The present invention relates to a process for producing an optically active (2S,3S)-3- hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4 (5H)-one (Cis-lactam). More particularly, this invention relates to a process for making...  
WO/2014/029498A1
The present invention provides dimers and sulfonyl dimers of the compound of formula (I) having antibacterial activities.  
WO/2014/030096A3
Microorganisms and processes for the recombinant manufacture of clavine-type alkaloids such as cycloclavine, festuclavine, agroclavine, chanoclavine and chanoclavine aldehyde, as well as polypeptides, polynucleotides and vectors comprisi...  
WO/2014/015256A2
Provided herein are enzymatic methods for oxidation of 5-hydroxymethylfurfural (HMF) and HMF derivatives.  
WO/2014/015256A3
Provided herein are enzymatic methods for oxidation of 5-hydroxymethylfurfural (HMF) and HMF derivatives.  
WO/2014/005408A1
Provided in the present invention are antibiotic Tetrathiazomycin A and the preparation method thereof and the use in the preparation of an antitumour drug. The structural formula of Tetrathiazomycin A is shown as formula (I). The presen...  
WO/2013/190341A1
The present invention relates to an enantioselective enzymatic process for the preparation of an optically active 3-hydroxypiperidinecarboxylic acid derivative.  
WO/2013/173784A1
The invention provides new processes for making and purifying salts of hydroxylated cyclopentapyrimidine compounds, which are useful as AKT inhibitors used in the treatment of diseases such as cancer, including the monohydrochloride salt...  
WO/2013/167088A3
The present invention provides a synthesis method for L-cyclic alkyl amino acid and a pharmaceutical composition having said acid. Said synthesis method comprises: step a.) preparing a cyclic alkyl keto acid or cyclic alkyl keto acid sal...  
WO/2013/169725A2
The present disclosure provides engineered proline hydroxylase polypeptides for the production of hydroxylated compounds, polynucleotides encoding the engineered proline hydroxylases, host cells capable of expressing the engineered proli...  
WO/2013/169610A1
The present invention is directed to processes for preparing an intermediate for a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorder...  
WO/2013/162478A1
There is provided a method of degrading a heterocyclic aldehyde compound comprising the step of treating the heterocyclic aldehyde compound with Enterobacter sp. microorganisms. There is also provided a method of degrading a carboxylic a...  
WO/2013/155868A1
Provided in the present invention is a method for increasing the yield of total flavonoids in Ganoderma lucidum mycelium with an expansin, comprising the steps of: (1) inoculating strains of Ganoderma lucidum into the PD liquid fermentat...  
WO/2013/153554A1
The present invention provides a novel method for producing rapamycin by submerged fermentation which comprises cultivating Streptomyces hygroscopicus (CBS 773.72) and mutants thereof. The present invention provides a high yielding mutan...  
WO/2013/143184A1
Provided is a streptomyces (Streptomyces sp.) strain SCSIO 03032, preserved in China Center for Type Culture Collection on July 18, 2011 with the preservation number CCTCC NO: M 2011258. The streptomyces (Streptomyces sp.) strain SCSIO 0...  
WO/2013/139987A1
The present invention relates to processes and intermediates useful for the manufacture of spiroindolone compounds such as (1'R,3'S)-5,7'-dichloro-6'-fluoro-3'-methyl-2',3',4',9'-tetr ahydrospiro[indoline-3,1'-pyrido[3, 4-b]indol]-2-one ...  
WO/2013/132118A1
The present invention relates to an isolated polynucleotide comprising ectoine- and hydroxyectoine-producing genes, preferably with at least two copies of the gene that encodes the ectoine hydroxylase enzyme, expression of which is direc...  
WO/2013/129661A1
The present invention provides a chroman derivative represented by general formula (I), which enables the production of an SMTP compound that has a desired structure. In the formula, each of Y1 and Y2 independently represents a hydrogen ...  
WO/2013/127915A1
Recombinant microbial cells and methods for producing melatonin and related compounds using such cells are described. More specifically, the recombinant microbial cell may comprise exogenous genes encoding one or more of an L-tryptophan ...  
WO/2013/127356A1
Provided are a preparation method of (R) - praziquantel and an intermediate thereof. 1-alkylcarbamoyl-3,4-dihydroisoquinoline or 1-ester-3,4-dihydroisoquinoline are used as starting materials of the preparation method; the starting m...  
WO/2013/127914A1
Recombinant microbial cells and methods for producing 5-hydroxytryptophan (5HTP) using such cells are described. More specifically, the recombinant microbial cell comprises an exogenous gene encoding an L-tryptophan hydroxylase, and mean...  
WO/2013/103246A2
The present invention relates to: a recombinant microorganism producing quinolinic acid which expresses a fusion protein in which L-aspartate oxidase and quinolinate synthase are linked by a linker; and a method for producing quinolinic ...  
WO/2013/103246A3
The present invention relates to: a recombinant microorganism producing quinolinic acid which expresses a fusion protein in which L-aspartate oxidase and quinolinate synthase are linked by a linker; and a method for producing quinolinic ...  
WO/2013/097424A1
Provided are a marine streptomyces sp., a compound of pyranosesquiterpenes and a preparation method and the use thereof. Streptomyces sp. SCSIO 01689 was deposited in the China Center for Type Culture Collection (CCTCC) on July 18, 2011,...  
WO/2013/095175A1
The invention relates to biotechnological industry, specifically to obtaining the substance of medicinal preparation stepharine sulfate out of the cell culture of Stephania glabra plant, and a method of quantitative determination of step...  
WO/2013/096898A3
Embodiments of the present invention relate to methods for the biosynthesis of di- or trifunctional C7 alkanes in the presence of isolated enzymes or in the presence of a recombinant host cell expressing those enzymes. The di- or trifunc...  
WO/2013/090837A3
This document describes biochemical pathways for producing adipic acid, caprolactam, 6-aminohexanoic acid, hexamethylenediamine or 1,6-hexanediol by forming two terminal functional groups, comprised of carboxyl, amine or hydroxyl groups,...  
WO/2013/090837A2
This document describes biochemical pathways for producing adipic acid, caprolactam, 6-aminohexanoic acid, hexamethylenediamine or 1,6-hexanediol by forming two terminal functional groups, comprised of carboxyl, amine or hydroxyl groups,...  
WO/2013/080219A3
The present invention relates to an improved process for the preparation of compound of Formula-II, which is an intermediate in the preparation of HMG-CoA reductase inhibitors. wherein X is hydrogen or hydroxy protecting group and Ri is ...  
WO/2013/075676A1
The microorganism strain Rhizobium radiobacter R89-1 CCM 7947, capable of hydroxylating codeine in position 14 to 14-hydroxycodeine of formula (2) and 14-hydroxycodeinone of formula (3) with 100% conversion of starting codeine of formula...  
WO/2013/074650A1
The present disclosure relates to engineered ketoreductase polypeptides for the preparation of hydroxyl substituted carbamate compounds, and polynucleotides, vectors, host cells, and methods of making and using the ketoreductase polypept...  
WO/2013/068917A1
The present application relates to a process for the preparation of lactones by enzymatic oxidation of lactols. The lactones, produced thus may be useful for the synthesis of statins, including but not limited to, cerivastatin, pitavasta...  
WO/2013/067719A1
Provided is a bioengineering strain for producing a new microbial fungicide and the use thereof, wherein the bioengineering strain is obtained by transforming a phzH gene recombinant expression plasmid into a strain producing phenazine-1...  
WO/2013/065383A1
A compound represented by structural formula (A) or a salt thereof. The compound or the salt thereof is produced suitably from a microorganism belonging to the genus Saccharothrix and can be used suitably as a prostaglandin production in...  
WO/2013/067432A1
The invention provides non-naturally occurring microbial organisms containing caprolactone pathways having at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce caprolactone. ...  
WO/2013/064687A2
The present invention belongs to the field of pharmaceutical industry and specifies the process for preparing clavulanic acid by using a microorganism, comprising the steps of providing a microorganism being capable of producing clavulan...  
WO/2013/064687A3
The present invention belongs to the field of pharmaceutical industry and specifies the process for preparing clavulanic acid by using a microorganism, comprising the steps of providing a microorganism being capable of producing clavulan...  
WO/2013/061919A1
The purpose of the present invention is to provide: a novel compound useful as an anti-mold substance; and a method for producing the compound. The present invention relates to: a compound represented by formula (I0) (wherein R1 represen...  
WO/2013/059507A1
The invention provides isolated nucleic acid encoding one or more gene products that allow for degradation of caffeine and related structures, and for preparation of intermediates in that catabolic pathway. Further provided are methods o...  
WO/2013/058582A2
The present invention relates to a preparation method for an ansamycin glycoside or a non-benzoquinone geldanamycin glycoside having an ansamycin backbone using a glycosyltransferase, a non-benzoquinone geldanamycin glycoside, and a phar...  
WO/2013/058582A3
The present invention relates to a preparation method for an ansamycin glycoside or a non-benzoquinone geldanamycin glycoside having an ansamycin backbone using a glycosyltransferase, a non-benzoquinone geldanamycin glycoside, and a phar...  
WO/2013/041935A1
The present invention provides a process for the preparation of lycopene containing oleoresin and lycopene crystals for human consumption. The present invention provides an efficient process for the preparation of lycopene crystals from ...  
WO/2013/036787A2
Provided herein are cell-free systems for generating carbapenems, e.g., a compound of the Formula (I): or salts thereof; wherein (II), R1, R2, R3, R4, R5, and R6 are defined herein. Also provided are pharmaceutical compositions comprisin...  

Matches 151 - 200 out of 8,402